Page last updated: 2024-12-06

4-methoxybenzonitrile

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

4-Methoxybenzonitrile, also known as p-methoxybenzonitrile, is an organic compound with the formula CH3OC6H4CN. It is a colorless solid that is used as an intermediate in the synthesis of various pharmaceuticals and agrochemicals. It is also a component of some perfumes. 4-methoxybenzonitrile can be synthesized by the reaction of 4-methoxyphenol with cyanogen bromide. It is known to be a potent inhibitor of certain enzymes, such as monoamine oxidase, and has been studied for its potential therapeutic properties. Its biological activity and potential applications in pharmaceuticals and agrochemicals make it a subject of ongoing research.'

4-methoxybenzonitrile: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID70129
CHEMBL ID482278
SCHEMBL ID103904
MeSH IDM0090268

Synonyms (59)

Synonym
HMS1760K15
BB 0258887
benzonitrile, 4-methoxy-
p-anisonitrile
874-90-8
4-methoxybenzonitrile
p-anisylnitrile
p-cyanoanisole
p-methoxyphenyl cyanide
p-methoxybenzonitrile
nsc3777
4-cyanoanisole
nsc-3777
NCIOPEN2_000576
nsc-71539
nsc71539
anisonitrile
1-methoxy-4-cyano-benzene
inchi=1/c8h7no/c1-10-8-4-2-7(6-9)3-5-8/h2-5h,1h
4-methoxybenzonitrile, 99%
A0493
AKOS000222426
CHEMBL482278
A21198
anisonitrile;1-cyano-4-methoxybenzene
nsc 3777
nsc 71539
einecs 212-871-6
ai3-11801
4-methoxy-benzonitrile
4-methoxy benzonitrile
4-anisonitrile
STL168356
BP-12473
FT-0618920
PS-4309
4-methoxybenzenecarbonitrile
AB00162
SCHEMBL103904
anisonitril
anisnitrile
4-methoxybenzonitril
1-cyano-4-methoxybenzene
dtxcid7031169
cas-874-90-8
tox21_304041
dtxsid0052596 ,
NCGC00357248-01
W-104017
STR00967
AC-26138
mfcd00001818
F0001-2177
Z53834531
CS-W013398
AMY4132
O11255
EN300-07853
O8C ,
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (2)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency7.16650.001530.607315,848.9004AID1224841; AID1259401
thyroid stimulating hormone receptorHomo sapiens (human)Potency61.13060.001628.015177.1139AID1224843
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
AID343398Octanol-water distribution coefficient, log D at pH 7.4 by shake-flask technique2008Journal of medicinal chemistry, Jul-10, Volume: 51, Issue:13
Toward prediction of alkane/water partition coefficients.
AID343680Hexadecane-water distribution coefficient, log D at pH 7.4 by shake-flask technique2008Journal of medicinal chemistry, Jul-10, Volume: 51, Issue:13
Toward prediction of alkane/water partition coefficients.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (16.67)18.7374
1990's1 (16.67)18.2507
2000's2 (33.33)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 32.61

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index32.61 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.66 (4.65)
Search Engine Demand Index35.52 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (32.61)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]